The Expression of CD90/Thy-1 in Hepatocellular Carcinoma: An In Vivo and In Vitro Study

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Sukowati, Caecilia Hapsari Ceriapuri ^a,c   Anfuso, Beatrice ^a   Torre, Giuliano ^b   Francalanci, Paola ^b   Crocè, Lory Saveria ^a,c   Tiribelli, Claudio ^a,c  

^a Centro Studi Fegato   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ALPHA SMOOTH MUSCLE ACTIN 2; BREAST CANCER RESISTANCE PROTEIN; FIBROBLAST ASSOCIATED PROTEIN; GROWTH PROMOTOR; MULTIDRUG RESISTANCE PROTEIN 1; SCATTER FACTOR; THY 1 ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BILE DUCT CARCINOMA; CELL PROLIFERATION; CLONOGENIC ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HEPATOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; TISSUE SECTION; UPREGULATION; WESTERN BLOTTING;

ACTINS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIGENS, THY-1; ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, NUDE; MICE, SCID; MICROSCOPY, FLUORESCENCE; NEOPLASM PROTEINS; P-GLYCOPROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 84885157812     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076830     Document Type: Article

References (33)

1. Parkin DM, Bray F, Ferlay J, Pisani P, (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94: 153-156. doi:10.1002/ijc.1440. PubMed: 11668491.
2. Llovet JM, Burroughs A, Bruix J, (2003) Hepatocellular carcinoma. Lancet 362: 1907-1917. doi:10.1016/S0140-6736(03)14964-1. PubMed: 14667750.
3. El-Serag HB, Rudolph KL, (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576. doi:10.1053/j.gastro.2007.04.061. PubMed: 17570226.
4. Simonetti RG, Cammà C, Fiorello F, Politi F, D'Amico G, et al. (1991) Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci 36: 962-972. doi:10.1007/BF01297149. PubMed: 1649041.
5. European, Association for The Study of The Liver, European Organisation For Research And Treatment Of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56: 908-943. PubMed: 22424438.
6. Rege TA, Hagood JS, (2006) Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis. FASEB J 20: 1045-1054. doi:10.1096/fj.05-5460rev. PubMed: 16770003.
7. Dennis JE, Esterly K, Awadallah A, Parrish CR, Poynter GM, et al. (2007) Clinical-scale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration. Stem Cells 25: 2575-2582. doi:10.1634/stemcells.2007-0204. PubMed: 17585167.
8. Herrera MB, Bruno S, Buttiglieri S, Tetta C, Gatti S, et al. (2006) Isolation and characterization of a stem cell population from adult human liver. Stem Cells 24: 2840-2850. doi:10.1634/stemcells.2006-0114. PubMed: 16945998.
9. Dan YY, Riehle KJ, Lazaro C, Teoh N, Haque J, et al. (2006) Isolation of multipotent progenitor cells from human fetal liver capable of differentiating into liver and mesenchymal lineages. Proc Natl Acad Sci U S A 103: 9912-9917. doi:10.1073/pnas.0603824103. PubMed: 16782807.
10. Lázaro CA, Croager EJ, Mitchell C, Campbell JS, Yu C, et al. (2003) Establishment, characterization, and long-term maintenance of cultures of human fetal hepatocytes. Hepatology 38: 1095-1106. doi:10.1053/jhep.2003.50448. PubMed: 14578848.
11. Pascal LE, Goo YA, Vêncio RZ, Page LS, Chambers AA, et al. (2009) Gene expression down-regulation in CD90+ prostate tumor-associated stromal cells involves potential organ-specific genes. BMC Cancer 9: 317. doi:10.1186/1471-2407-9-317. PubMed: 19737398.
12. True LD, Zhang H, Ye M, Huang CY, Nelson PS, et al. (2010) CD90/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarker. Mod Pathol 23: 1346-1356. doi:10.1038/modpathol.2010.122. PubMed: 20562849.
13. Yu XH, Xu LB, Liu C, Zhang R, Wang J, (2011) Clinicopathological characteristics of 20 cases of hepatocellular carcinoma with bile duct tumor thrombi. Dig Dis Sci 56: 252-259. doi:10.1007/s10620-010-1256-8. PubMed: 20437099.
14. Lingala S, Cui YY, Chen X, Ruebner BH, Qian XF, et al. (2010) Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma. Exp Mol Pathol 89: 27-35. doi:10.1016/j.yexmp.2010.05.005. PubMed: 20511115.
15. Lu JW, Chang JG, Yeh KT, Chen RM, Tsai JJ, et al. (2011) Overexpression of Thy1/CD90 in human hepatocellular carcinoma is associated with HBV infection and poor prognosis. Acta Histochem 113: 833-838. doi:10.1016/j.acthis.2011.01.001. PubMed: 21272924.
16. Yang ZF, Ngai P, Ho DW, Yu WC, Ng MN, et al. (2008) Identification of local and circulating cancer stem cells in human liver cancer. Hepatology 47: 919-928. doi:10.1002/hep.22082. PubMed: 18275073.
17. Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, et al. (2008) Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 13: 153-166. doi:10.1016/j.ccr.2008.01.013. PubMed: 18242515.
18. Yamashita T, Honda M, Nakamoto Y, Baba M, Nio K, et al. (2013) Discrete nature of EpCAM(+) and CD90(+) cancer stem cells in human hepatocellular carcinoma. Hepatology 57: 1484-1497. doi:10.1002/hep.26168. PubMed: 23174907.
19. Ho DW, Yang ZF, Yi K, Lam CT, Ng MN, et al. (2012) Gene expression profiling of liver cancer stem cells by RNA-sequencing. PLOS ONE 7: e37159. doi:10.1371/journal.pone.0037159. PubMed: 22606345.
20. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, et al. (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55: 611-622. doi:10.1373/clinchem.2008.112797. PubMed: 19246619.
21. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45. doi:10.1093/nar/29.9.e45. PubMed: 11328886.
22. Tichopad A, Didier A, Pfaffl MW, (2004) Inhibition of real-time RT-PCR quantification due to tissue-specific contaminants. Mol Cell Probes 18: 45-50. doi:10.1016/j.mcp.2003.09.001. PubMed: 15036369.
23. Viegas MS, Martins TC, Seco F, do CA, (2007) An improved and cost-effective methodology for the reduction of autofluorescence in direct immunofluorescence studies on formalin-fixed paraffin-embedded tissues. Eur J Histochem 51: 59-66. PubMed: 17548270.
24. Paulusma CC, van Geer MA, Evers R, Heijn M, Ottenhoff R, et al. (1999) Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Biochem J 338(2):: 393-401. doi:10.1042/0264-6021:3380393. PubMed: 10024515.
25. Mazzocca A, Fransvea E, Dituri F, Lupo L, Antonaci S, et al. (2010) Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma. Hepatology 51: 523-534. doi:10.1002/hep.23285. PubMed: 19821534.
26. Dudas J, Mansuroglu T, Batusic D, Ramadori G, (2009) Thy-1 is expressed in myofibroblasts but not found in hepatic stellate cells following liver injury. Histochem Cell Biol 131: 115-127. doi:10.1007/s00418-008-0503-y. PubMed: 18797914.
27. Cesselli D, Beltrami AP, Poz A, Marzinotto S, Comisso E, et al. (2011) Role of tumor associated fibroblasts in human liver regeneration, cirrhosis, and cancer. Int J Hepatol(2011): pp. 120925. PubMed: 22187657.
28. Fujise K, Nagamori S, Hasumura S, Homma S, Sujino H, et al. (1990) Integration of hepatitis B virus DNA into cells of six established human hepatocellular carcinoma cell lines. Hepatogastroenterology 37: 457-460. PubMed: 1701409.
29. Zen Y, Fujii T, Yoshikawa S, Takamura H, Tani T, et al. (2007) Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma. Am J Pathol 170: 1750-1762. doi:10.2353/ajpath.2007.060798. PubMed: 17456779.
30. Zhao H, Peehl DM, (2009) Tumor-promoting phenotype of CD90hi prostate cancer-associated fibroblasts. Prostate 69: 991-1000. doi:10.1002/pros.20946. PubMed: 19267366.
31. Apáti A, Orbán TI, Varga N, Németh A, Schamberger A, et al. (2008) High level functional expression of the ABCG2 multidrug transporter in undifferentiated human embryonic stem cells. Biochim Biophys Acta 1778: 2700-2709. doi:10.1016/j.bbamem.2008.08.010. PubMed: 18793608.
32. Scharenberg CW, Harkey MA, Torok-Storb B, (2002) The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 99: 507-512. doi:10.1182/blood.V99.2.507. PubMed: 11781231.
33. Murakami K, Sakukawa R, Ikeda T, Matsuura T, Hasumura S, et al. (1999) Invasiveness of hepatocellular carcinoma cell lines: contribution of membrane-type 1 matrix metalloproteinase. Neoplasia 1: 424-430. doi:10.1038/sj.neo.7900046. PubMed: 10933057.